Product Images Duloxetine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Duloxetine NDC 50090-2844 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1: Kaplan-Meier Estimation of Cumulative Proportion of Patients with Relapse (MDD Study 5) - duloxetine fig1

Figure 1: Kaplan-Meier Estimation of Cumulative Proportion of Patients with Relapse (MDD Study 5) - duloxetine fig1

fig2 - duloxetine fig2

fig2 - duloxetine fig2

Figure 3: Percentage of Patients Achieving Various Levels of Pain Relief as Measured by 24-Hour Average Pain Severity - DPNP-1 - duloxetine fig3

Figure 3: Percentage of Patients Achieving Various Levels of Pain Relief as Measured by 24-Hour Average Pain Severity - DPNP-1 - duloxetine fig3

Figure 4: Percentage of Patients Achieving Various Levels of Pain Relief as Measured by 24-Hour Average Pain Severity - DPNP-2 - duloxetine fig4

Figure 4: Percentage of Patients Achieving Various Levels of Pain Relief as Measured by 24-Hour Average Pain Severity - DPNP-2 - duloxetine fig4

Figure 7: Percentage of Patients Achieving Various Levels of Pain Relief as Measured by 24-Hour Average Pain Severity – CLBP-1 - duloxetine fig5

Figure 7: Percentage of Patients Achieving Various Levels of Pain Relief as Measured by 24-Hour Average Pain Severity – CLBP-1 - duloxetine fig5

The text represents a graph showing the percentage of patients who reported improvement in pain after using a medication. The x-axis shows the percentage of improvement in pain from baseline, while the y-axis shows the percentage of patients who reported improvement. The graph includes three lines, representing Duloxetine 60 mg twice daily, Duloxetine 60 mg once daily, and a placebo. The data shows that the percentage of patients who reported improvement increased as the percentage of improvement in pain increased.*

Figure 8: Percentage of Patients Achieving Various Levels of Pain Relief as Measured by 24-Hour Average Pain Severity – CLBP-3 - duloxetine fig6

Figure 8: Percentage of Patients Achieving Various Levels of Pain Relief as Measured by 24-Hour Average Pain Severity – CLBP-3 - duloxetine fig6

This appears to be a graph or chart showing the percentage of patients who experienced improvement in pain levels after taking Duloxetine at different dosages. The dosages listed are 120mg, 60mg, and 20mg taken once daily. The graph also includes a placebo line for comparison.*

Figure 9: Percentage of Patients Achieving Various Levels of Pain Relief as Measured by 24-Hour Average Pain Severity – OA-1 - duloxetine fig7

Figure 9: Percentage of Patients Achieving Various Levels of Pain Relief as Measured by 24-Hour Average Pain Severity – OA-1 - duloxetine fig7

The text shows a chart that compares the percentage of patients who improved their pain levels after taking either a placebo or a medication called Duloxetine 60/120 mg once. The chart indicates that all patients who took Duloxetine saw an improvement in their condition, while the placebo group didn't show any improvement. Additionally, the chart includes a table with values ranging from 0 to 100, which seems to indicate the percent improvement in pain from baseline, using the BOCF method.*

duloxetine fig8

duloxetine fig8

duloxetine fig9

duloxetine fig9

The text appears to be a graph displaying the percentage of pain improvement from baseline (BOCF) for patients taking Placeto and Dulowetine at 60/120 mg once daily. There are no additional details or context provided.*

Structure - duloxetine str

Structure - duloxetine str

Label Image - lbl500902844

Label Image - lbl500902844

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.